Antimicrobial Susceptibility Testing of the Combination of Aztreonam and Avibactam in NDM-Producing <i>Enterobacterales</i>: A Comparative Evaluation Using the CLSI and EUCAST Methods
<b>Background</b>: The combination of aztreonam (ATM) and avibactam (AVI) presents an important therapeutic option for carbapenem-resistant <i>Enterobacterales</i>, particularly the NDM-producing <i>Enterobacterales</i>. In 2024, both the CLSI and EUCAST published...
Saved in:
| Main Authors: | Linda Mei-Wah Chan, Doris Yui Ling Lok, River Chun Wai Wong, Alfred Lok-Hang Lee, Ingrid Yu-Ying Cheung, Christopher Koon-Chi Lai, Viola C. Y. Chow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/7/675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Susceptibility of Enterobacterales Collected in the Middle East and Turkey to Aztreonam/Avibactam and Comparator Agents Stratified by Infection Source: ATLAS Surveillance Program 2018-2022
by: Mark Wise, et al.
Published: (2024-12-01) -
Whole-genome analysis of NDM-producing Providencia hangzhouensis associated with recurrent bacteraemia with rapid development of aztreonam-avibactam resistance
by: Ka Lip Chew, et al.
Published: (2025-12-01) -
In Vitro Activity of Aztreonam-avibactam and Comparator Agents Against Carbapenemase-producing Enterobacterales Collected in Turkey and the Middle East as Part of the ATLAS Surveillance Program: 2018-2022
by: Mark Estabrook, et al.
Published: (2024-12-01) -
Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam–Avibactam and Comparator Agents (2019–2023)
by: Helio S. Sader, et al.
Published: (2025-04-01) -
In vitro activity of aztreonam–avibactam combination against blood culture isolates of Stenotrophomonas maltophilia in Japan before the launch of ceftazidime–avibactam
by: Wataru Aoki, et al.
Published: (2025-05-01)